Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Progra
The Table below, updated weekly, contains newly reported, covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the Drug Products in the Medicaid Drug Rebate Program (MDRP) database. Each file on this table represents a snapshot of data in the system and is not updated by subsequent changes. Once the covered outpatient drugs in each of these files appear in the quarterly MDRP database, the file will be removed from this table. States can utilize these files to identify newly reported covered outpatient drugs.
| Type | Year | Month | Date |
|---|---|---|---|
| Type | Year | Month | Date |
OR-21-0014
CMS is approving this time-limited state plan amendment (SPA) to respond to the COVID-19 national emergency. The purpose of this amendment to include coverage and reimbursement for the administration of monoclonal antibody treatment or any drug treatment authorized under an FDA Emergency Use Authorization for COVID-19.
CO-21-0026
CMS is approving this time-limited state plan amendment (SPA) to respond to the COVID-19 national emergency. The purpose of this amendment to establish a July 2021 COVID-19 interim payment for primary care medical providers (PCMP) who provide integrated services. PCMPs who received a February 2021 (approved in TN 21-0003) or October 2020 COVID-19 interim payment (approved in TN 20-0035) are not eligible to receive the July 2021 COVID-19 interim payment.
GA-21-0005
CMS is approving this time-limited state plan amendment (SPA) to respond to the COVID-19 national emergency. The purpose of this amendment to increase the reimbursement rates for the COVID-19 Vaccine to 100 percent of the Medicare reimbursement rate ($40.00 per dose) beginning April 1, 2021 through the end of the Public Health Emergency.
Section 1135 Waiver Flexibilities - Arkansas Coronavirus Disease 2019 (Fourth Request)
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Arkansas for multiple section 1135 flexibilities on April 2, 2020. Your follow-up communication to CMS on September 14, 2021, detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Arkansas and requested a waiver or modification of those additional requirements.
Collections:
CO-21-0010
This amendment extends the adult dental benefit maximum of $1,500